Celaxia Co.
Latest round
- Series C
Last raised
- Jun 2024
Total raised
- $12M
Investors
- 12
About Celaxia Co.
Based in Tokyo, Japan, and founded in 2017 by CEO Makoto Seki, CellAxia Inc. operates as a biopharmaceutical company specializing in regenerative medicine. The company engages in the research, development, manufacturing, and sale of pharmaceuticals. In June 2024, CellAxia Inc. CellAxia Inc. specializes in research and development for the pharmaceuticals industry. The firm manufactures and sales pharmaceuticals and regenerative medicine products.
Who invested in Celaxia Co.
12 investors across 3 rounds
See all investors in Celaxia Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Celaxia Co.
Who invested in Celaxia Co.?
Celaxia Co. has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Celaxia Co. raised?
Celaxia Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Celaxia Co. last raise money?
Celaxia Co.'s most recent round on record is a Series C, in Jun 2024.
What does Celaxia Co. do?
Based in Tokyo, Japan, and founded in 2017 by CEO Makoto Seki, CellAxia Inc.
Where is Celaxia Co. headquartered?
Celaxia Co. is headquartered in Tokyo, Japan.
Which VCs invest in companies like Celaxia Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Celaxia Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Celaxia Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.